Louis Libbrecht

10.3k total citations · 1 hit paper
170 papers, 7.5k citations indexed

About

Louis Libbrecht is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Louis Libbrecht has authored 170 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hepatology, 59 papers in Surgery and 49 papers in Oncology. Recurrent topics in Louis Libbrecht's work include Liver Disease Diagnosis and Treatment (33 papers), Liver physiology and pathology (25 papers) and Hepatocellular Carcinoma Treatment and Prognosis (21 papers). Louis Libbrecht is often cited by papers focused on Liver Disease Diagnosis and Treatment (33 papers), Liver physiology and pathology (25 papers) and Hepatocellular Carcinoma Treatment and Prognosis (21 papers). Louis Libbrecht collaborates with scholars based in Belgium, Netherlands and United States. Louis Libbrecht's co-authors include Tania Roskams, Valeer Desmet, David Cassiman, Frederik Nevens, Rita De Vos, Chris Verslype, Carl Denef, Jacques Pirenne, Sara Vander Borght and Pál Kaposi-Novák and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Louis Libbrecht

160 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

2006 722 citations Louis Libbrecht, Pál Kaposi-Novák et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louis Libbrecht Belgium	48	3.5k	2.3k	2.1k	2.1k	2.0k	170	7.5k
Jiro Fujimoto Japan	39	2.6k 0.8×	2.2k 1.0×	1.5k 0.7×	2.1k 1.0×	1.5k 0.8×	185	7.1k
Hans Peter Dienes Germany	48	2.3k 0.7×	2.1k 0.9×	2.4k 1.1×	1.8k 0.8×	1.4k 0.7×	130	6.9k
Kwan Man Hong Kong	53	2.1k 0.6×	1.4k 0.6×	1.8k 0.8×	3.2k 1.5×	1.5k 0.7×	176	7.7k
Ronnie T.P. Poon Hong Kong	55	4.0k 1.2×	1.5k 0.6×	2.0k 1.0×	3.1k 1.5×	2.0k 1.0×	106	8.4k
Kenichi Wakasa Japan	40	2.2k 0.6×	1.5k 0.7×	2.1k 1.0×	1.2k 0.6×	1.5k 0.8×	260	6.5k
Shuang–Jian Qiu China	48	2.1k 0.6×	1.8k 0.8×	2.0k 0.9×	2.7k 1.3×	3.6k 1.8×	174	8.6k
Toshimasa Asahara Japan	45	2.0k 0.6×	1.9k 0.8×	1.1k 0.5×	2.4k 1.2×	1.1k 0.6×	274	6.4k
Motoko Sasaki Japan	52	2.0k 0.6×	5.0k 2.2×	2.1k 1.0×	2.5k 1.2×	2.2k 1.1×	238	8.8k
Fumihiko Kanai Japan	54	2.1k 0.6×	1.4k 0.6×	1.8k 0.8×	4.3k 2.1×	1.8k 0.9×	158	8.7k
Iwao Ikai Japan	54	6.6k 1.9×	4.1k 1.8×	3.5k 1.6×	1.7k 0.8×	2.1k 1.1×	221	10.3k

Countries citing papers authored by Louis Libbrecht

Since Specialization

Citations

This map shows the geographic impact of Louis Libbrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Libbrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Libbrecht more than expected).

Fields of papers citing papers by Louis Libbrecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Libbrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Libbrecht. The network helps show where Louis Libbrecht may publish in the future.

Co-authorship network of co-authors of Louis Libbrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Libbrecht. A scholar is included among the top collaborators of Louis Libbrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Libbrecht. Louis Libbrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Claerhout, Sofie, Sara Vander Borght, Lien Spans, et al.. (2024). Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours. The Journal of Pathology Clinical Research. 10(3). e12376–e12376. 1 indexed citations

Libbrecht, Louis, et al.. (2023). Epithelioid Fibrous Histiocytoma with CARS-ALK Fusion: First Case Report. SHILAP Revista de lepidopterología. 10(1). 25–29. 2 indexed citations

Gilbo, Nicholas, Tine Wylin, Louis Libbrecht, et al.. (2023). The Distinct Innate Immune Response of Warm Ischemic Injured Livers during Continuous Normothermic Machine Perfusion. International Journal of Molecular Sciences. 24(16). 12831–12831. 1 indexed citations

Libbrecht, Louis, et al.. (2023). Olmesartan induced weight loss and small vessel vasculitis. Acta Gastro Enterologica Belgica. 86(1). 102–104. 1 indexed citations

Bockstal, Mieke Van, et al.. (2022). Breast-implant Related Silicone Lymphadenopathy: Asteroid Bodies do not Always Equal Sarcoidosis!. International Journal of Surgical Pathology. 31(6). 1099–1104. 2 indexed citations

Muilwijk, Tim, Murat Akand, Frank Van der Aa, et al.. (2021). Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer. Journal of Cellular and Molecular Medicine. 25(16). 7890–7900. 9 indexed citations

Martínez‐Corral, Inés, Yan Zhang, Henrik Ortsäter, et al.. (2020). Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation. Nature Communications. 11(1). 2869–2869. 70 indexed citations

Libbrecht, Louis, et al.. (2020). Auto-immune gastritis induced by pembrolizumab, an anti-PD-1, in a melanoma patient.. Lirias (KU Leuven). 83(3). 482–484. 14 indexed citations

Toussaint, C., et al.. (2019). Endoscopic features, pathological correlates and possible origin of foveolar gastric metaplasia presenting as a duodenal polyp.. PubMed. 82(2). 257–260.

10.

Gevaert, Thomas, Rodolfo Montironi, Antonio López-Beltrán, et al.. (2017). Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatment. Seminars in Cancer Biology. 52(Pt 2). 216–227. 12 indexed citations

11.

Gevaert, Thomas, Xavier Moles Lopez, Xavier Sagaert, et al.. (2015). Morphometric and Quantitative Immunohistochemical Analysis of Disease-Related Changes in the Upper (Suburothelial) Lamina Propria of the Human Bladder Dome. PLoS ONE. 10(5). e0127020–e0127020. 9 indexed citations

12.

Malenstein, Hannah van, Olivier Gevaert, Louis Libbrecht, et al.. (2010). A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma. Clinical Cancer Research. 16(16). 4278–4288. 49 indexed citations

13.

Kaposi-Novák, Pál, Louis Libbrecht, Hyun Goo Woo, et al.. (2009). Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis. Cancer Research. 69(7). 2775–2782. 149 indexed citations

14.

Debucquoy, Annelies, Maarten Lambrecht, Sarah Roels, et al.. (2009). DOUBLE BLIND RANDOMIZED PHASE II STUDY WITH RADIATION+5-FLUOROURACIL +/- CELECOXIB FOR RESECTABLE RECTAL CANCER. Ghent University Academic Bibliography (Ghent University). 11 indexed citations

15.

Borght, Sara Vander, Mina Komuta, Louis Libbrecht, et al.. (2008). Expression of multidrug resistance‐associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin. Liver International. 28(10). 1370–1380. 86 indexed citations

16.

Rebouissou, Sandra, Gabrielle Couchy, Louis Libbrecht, et al.. (2008). The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. Journal of Hepatology. 49(1). 61–71. 56 indexed citations

17.

Borght, Sara Vander, Louis Libbrecht, Hans Blokzijl, et al.. (2005). Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. The Journal of Pathology. 207(4). 471–482. 70 indexed citations

18.

Meuleman, Philip, Louis Libbrecht, Robin Vos, Tania Roskams, & Geert Leroux‐Roels. (2004). Cytopathic effects of hepatitis B virus infection in long-term infected chimeric uPA-SCID mice. Hepatology. 40(4). 267. 1 indexed citations

19.

Libbrecht, Louis, Valeer Desmet, Boudewijn Van Damme, & Tania Roskams. (2000). The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. Journal of Hepatology. 33(1). 76–84. 130 indexed citations

20.

Libbrecht, Louis, Valeer Desmet, Bart Van Damme, & Tania Roskams. (2000). The expression of P16 in liver cell dysplasia in human cirrhotic liver. Hepatology. 32(4). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact